SaNOtize Research & Development Corp.
PrivateLast Round
Series B
Aug 24, 2022
Total Funding Raised
$24.45M
Company Overview
SaNOtize Research & Development Corp. operates in Healthcare & Life Sciences and is based in Vancouver. Its latest recorded funding round was a Series B round in August 2022.
SaNOtize Research & Development Corp. is a pharmaceutical company that develops and commercializes nitric oxide-based antimicrobial therapeutics for the treatment and prevention of viral, bacterial, and fungal infections.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Medical Devices, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting, Hardware Sales
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
SaNOtize Research & Development Corp. Comparables
Compare SaNOtize Research & Development Corp. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Enzymatica | 79% | |
| Firebrick Pharma Ltd | 78% | |
| Birmingham Biotech Ltd | 78% |
For institutional investors. Book with your work email.
SaNOtize Research & Development Corp. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Aug 24, 2022 | ||||
| VC Round | Mar 12, 2020 | ||||
| Seed | Feb 1, 2019 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
SaNOtize Research & Development Corp. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Horizons Ventures | Series B |
| Agricultural Bank of China International | Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 19, 2025
Grew 20% QoQ, from 20 to 24 employees.
- Feb 1, 2019
$450K raised in Seed round.
For institutional investors. Book with your work email.
SaNOtize Research & Development Corp. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about SaNOtize Research & Development Corp.'s valuation, stock price, and market status.
Is SaNOtize Research & Development Corp. a public or private company?
SaNOtize Research & Development Corp. is a private company.
What is the current stock price of SaNOtize Research & Development Corp.?
SaNOtize Research & Development Corp. is a private company, so its shares have no public market price. Caplight tracks SaNOtize Research & Development Corp.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is SaNOtize Research & Development Corp. worth (valuation)?
Valuation information for SaNOtize Research & Development Corp. is not publicly available.
Can I buy SaNOtize Research & Development Corp. stock?
SaNOtize Research & Development Corp. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was SaNOtize Research & Development Corp.'s last funding round?
SaNOtize Research & Development Corp.'s most recent funding round was Series B on August 24, 2022.
Who are the main investors in SaNOtize Research & Development Corp.?
Key investors in SaNOtize Research & Development Corp. include Horizons Ventures.
Will SaNOtize Research & Development Corp. IPO soon?
No public IPO plans have been announced for SaNOtize Research & Development Corp..
How can I track SaNOtize Research & Development Corp. secondary market activity?
Caplight tracks bids, offers, and trades in SaNOtize Research & Development Corp.'s shares on secondary markets.